- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: OM 174 | OM-174
Compound class: Natural product or derivative
Comment: Defoslimod is an analogue of lipopolysaccharide endotoxin-derived lipid A obtained from E. coli . It was developed as an immunotherapeutic agent for the treatment of cancer. Defoslimod acts as an agonist of Toll-like receptors 2 and 4 (TLR2 and TLR4) .
We show the structure with chemical formula provided in the INN record for the compound (C52H100N2O20P2). PubChem CID 56841121, which claims to represent defoslimod has an extra carbon atom and two associated hydrogens (C53H102N2O20P2). But note also that the structure reported in  only has 51 carbon atoms.
|No information available.|
|Summary of Clinical Use|
|OM-174 has completed a single Phase 1 clinical trial which was assessing its anti-tumour effect in patients with solid tumours (NCT01800812) .|
|Clinical Trial ID||Title||Type||Source||Comment||References|
|NCT01800812||Effects of OM-174 in Adult Patients With Solid Tumors||Phase 1 Interventional||Centre Hospitalier Universitaire Dijon|